关键信息
-
基因名
CDA2
- 应用
-
别名
CDA2; YLR308W; L2142.1Chitin deacetylase 2; EC 3.5.1.41
-
种属
Saccharomyces cerevisiae
-
表达系统
Yeast
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q06703
-
表达区间
26-312aa
-
分子量
34.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
CDA2 recombinant protein research is rooted in the growing interest in enzyme therapy and its potential applications in biotechnology and medicine. CDA2, or cytidine deaminase type 2, is an enzyme that plays a crucial role in nucleotide metabolism by catalyzing the deamination of cytidine and deoxycytidine to uridine and deoxyuridine, respectively. This enzymatic activity is significant in various biological processes, including antiviral responses and the regulation of cellular metabolism. Given the importance of nucleotide metabolism in a range of diseases, including cancer and viral infections, understanding CDA2's structure and function through recombinant protein studies can provide insights into its therapeutic potential. Researchers have focused on producing CDA2 in recombinant systems to study its biophysical properties, enzymatic mechanisms, and potential applications in drug development. By utilizing techniques like gene cloning, expression in bacterial systems, and subsequent purification, scientists aim to generate sufficient quantities of the enzyme for further investigations. Additionally, the study of CDA2's interactions with substrates and inhibitors may reveal novel therapeutic strategies for diseases where nucleotide metabolic pathways are dysregulated. Overall, CDA2 recombinant protein research holds promise for advancing our understanding of enzymatic functions and their applications in medicine and biotechnology.
